Neriifolin
Neriifolin is a cardiac glycoside and Na+/K+-ATPase inhibitor derived from Cerbera manghas. It exhibits anticancer properties by inducing cell cycle arrest and apoptosis in vitro in leukemia (THP-1) and liver cancer (HepG2) cell lines, and is also used in prostate cancer research.
Product Specifications
CAS Number
466-07-9
Product Name Alternative
NSC 123976, NSC123976, Na+/K+ ATPase, Autophagy, Apoptosis, 17β-Neriifolin, 17beta-Neriifolin
Field of Research
Cell Biology, Pharmacology & Drug Discovery
Purity
98.59% (May vary between batches)
Solubility
DMSO:80 mg/mL (149.62 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.17 mM)
Smiles
O[C@@]12[C@]3 ([C@@] ([C@]4 (C) [C@] (CC3) (C[C@@H] (O[C@H]5[C@@H] (O) [C@H] (OC) [C@@H] (O) [C@H] (C) O5) CC4) [H]) (CC[C@]1 (C) [C@H] (CC2) C6=CC (=O) OC6) [H]) [H]
Molecular Formula
C30H46O8
Molecular Weight
534.68
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog